0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Site-Directed Mutagenesis Services Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-11V17534
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Site Directed Mutagenesis Services Market Research Report 2024
BUY CHAPTERS

Global Gene Site-Directed Mutagenesis Services Market Research Report 2024

Code: QYRE-Auto-11V17534
Report
May 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Site-Directed Mutagenesis Services Market

The global Gene Site-Directed Mutagenesis Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Gene Site-Directed Mutagenesis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Site-Directed Mutagenesis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Site-Directed Mutagenesis Services in Medical Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Site-Directed Mutagenesis Services include ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Site-Directed Mutagenesis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Site-Directed Mutagenesis Services.
The Gene Site-Directed Mutagenesis Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Site-Directed Mutagenesis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Site-Directed Mutagenesis Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Site-Directed Mutagenesis Services Market Report

Report Metric Details
Report Name Gene Site-Directed Mutagenesis Services Market
Segment by Type
  • Synonymous Mutations
  • Missense Mutation
  • Nonsense Mutation
Segment by Application
  • Medical Industry
  • Biological Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, Genewiz, GenScript
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Site-Directed Mutagenesis Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The main players in the Gene Site-Directed Mutagenesis Services Market are ACGT, Azenta Life Sciences, Biocompare, NovoPro Bioscience Inc., Charles River, NZYtech, Thermofisher, Creatve Biolabs, Epoch Life Science, GeneToProtein, Genewiz, GenScript

What are the Application segmentation covered in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The Applications covered in the Gene Site-Directed Mutagenesis Services Market report are Medical Industry, Biological Research, Others

What are the Type segmentation covered in the Gene Site-Directed Mutagenesis Services Market report?

Ans: The Types covered in the Gene Site-Directed Mutagenesis Services Market report are Synonymous Mutations, Missense Mutation, Nonsense Mutation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Synonymous Mutations
1.2.3 Missense Mutation
1.2.4 Nonsense Mutation
1.3 Market by Application
1.3.1 Global Gene Site-Directed Mutagenesis Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Industry
1.3.3 Biological Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Site-Directed Mutagenesis Services Market Perspective (2019-2030)
2.2 Global Gene Site-Directed Mutagenesis Services Growth Trends by Region
2.2.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Site-Directed Mutagenesis Services Historic Market Size by Region (2019-2024)
2.2.3 Gene Site-Directed Mutagenesis Services Forecasted Market Size by Region (2025-2030)
2.3 Gene Site-Directed Mutagenesis Services Market Dynamics
2.3.1 Gene Site-Directed Mutagenesis Services Industry Trends
2.3.2 Gene Site-Directed Mutagenesis Services Market Drivers
2.3.3 Gene Site-Directed Mutagenesis Services Market Challenges
2.3.4 Gene Site-Directed Mutagenesis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Site-Directed Mutagenesis Services Players by Revenue
3.1.1 Global Top Gene Site-Directed Mutagenesis Services Players by Revenue (2019-2024)
3.1.2 Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Players (2019-2024)
3.2 Global Gene Site-Directed Mutagenesis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Site-Directed Mutagenesis Services Revenue
3.4 Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio
3.4.1 Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Site-Directed Mutagenesis Services Revenue in 2023
3.5 Global Key Players of Gene Site-Directed Mutagenesis Services Head office and Area Served
3.6 Global Key Players of Gene Site-Directed Mutagenesis Services, Product and Application
3.7 Global Key Players of Gene Site-Directed Mutagenesis Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Site-Directed Mutagenesis Services Breakdown Data by Type
4.1 Global Gene Site-Directed Mutagenesis Services Historic Market Size by Type (2019-2024)
4.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (2025-2030)
5 Gene Site-Directed Mutagenesis Services Breakdown Data by Application
5.1 Global Gene Site-Directed Mutagenesis Services Historic Market Size by Application (2019-2024)
5.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Site-Directed Mutagenesis Services Market Size (2019-2030)
6.2 North America Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024)
6.4 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Site-Directed Mutagenesis Services Market Size (2019-2030)
7.2 Europe Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024)
7.4 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size (2019-2030)
8.2 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Site-Directed Mutagenesis Services Market Size (2019-2030)
9.2 Latin America Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024)
9.4 Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size (2019-2030)
10.2 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACGT
11.1.1 ACGT Company Details
11.1.2 ACGT Business Overview
11.1.3 ACGT Gene Site-Directed Mutagenesis Services Introduction
11.1.4 ACGT Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.1.5 ACGT Recent Development
11.2 Azenta Life Sciences
11.2.1 Azenta Life Sciences Company Details
11.2.2 Azenta Life Sciences Business Overview
11.2.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Introduction
11.2.4 Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.2.5 Azenta Life Sciences Recent Development
11.3 Biocompare
11.3.1 Biocompare Company Details
11.3.2 Biocompare Business Overview
11.3.3 Biocompare Gene Site-Directed Mutagenesis Services Introduction
11.3.4 Biocompare Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.3.5 Biocompare Recent Development
11.4 NovoPro Bioscience Inc.
11.4.1 NovoPro Bioscience Inc. Company Details
11.4.2 NovoPro Bioscience Inc. Business Overview
11.4.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Introduction
11.4.4 NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.4.5 NovoPro Bioscience Inc. Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Gene Site-Directed Mutagenesis Services Introduction
11.5.4 Charles River Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.5.5 Charles River Recent Development
11.6 NZYtech
11.6.1 NZYtech Company Details
11.6.2 NZYtech Business Overview
11.6.3 NZYtech Gene Site-Directed Mutagenesis Services Introduction
11.6.4 NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.6.5 NZYtech Recent Development
11.7 Thermofisher
11.7.1 Thermofisher Company Details
11.7.2 Thermofisher Business Overview
11.7.3 Thermofisher Gene Site-Directed Mutagenesis Services Introduction
11.7.4 Thermofisher Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.7.5 Thermofisher Recent Development
11.8 Creatve Biolabs
11.8.1 Creatve Biolabs Company Details
11.8.2 Creatve Biolabs Business Overview
11.8.3 Creatve Biolabs Gene Site-Directed Mutagenesis Services Introduction
11.8.4 Creatve Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.8.5 Creatve Biolabs Recent Development
11.9 Epoch Life Science
11.9.1 Epoch Life Science Company Details
11.9.2 Epoch Life Science Business Overview
11.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Introduction
11.9.4 Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.9.5 Epoch Life Science Recent Development
11.10 GeneToProtein
11.10.1 GeneToProtein Company Details
11.10.2 GeneToProtein Business Overview
11.10.3 GeneToProtein Gene Site-Directed Mutagenesis Services Introduction
11.10.4 GeneToProtein Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.10.5 GeneToProtein Recent Development
11.11 Genewiz
11.11.1 Genewiz Company Details
11.11.2 Genewiz Business Overview
11.11.3 Genewiz Gene Site-Directed Mutagenesis Services Introduction
11.11.4 Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.11.5 Genewiz Recent Development
11.12 GenScript
11.12.1 GenScript Company Details
11.12.2 GenScript Business Overview
11.12.3 GenScript Gene Site-Directed Mutagenesis Services Introduction
11.12.4 GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024)
11.12.5 GenScript Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Synonymous Mutations
 Table 3. Key Players of Missense Mutation
 Table 4. Key Players of Nonsense Mutation
 Table 5. Global Gene Site-Directed Mutagenesis Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Gene Site-Directed Mutagenesis Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Gene Site-Directed Mutagenesis Services Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2019-2024)
 Table 9. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2025-2030)
 Table 11. Gene Site-Directed Mutagenesis Services Market Trends
 Table 12. Gene Site-Directed Mutagenesis Services Market Drivers
 Table 13. Gene Site-Directed Mutagenesis Services Market Challenges
 Table 14. Gene Site-Directed Mutagenesis Services Market Restraints
 Table 15. Global Gene Site-Directed Mutagenesis Services Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Gene Site-Directed Mutagenesis Services Market Share by Players (2019-2024)
 Table 17. Global Top Gene Site-Directed Mutagenesis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2023)
 Table 18. Ranking of Global Top Gene Site-Directed Mutagenesis Services Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Gene Site-Directed Mutagenesis Services Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Gene Site-Directed Mutagenesis Services, Headquarters and Area Served
 Table 21. Global Key Players of Gene Site-Directed Mutagenesis Services, Product and Application
 Table 22. Global Key Players of Gene Site-Directed Mutagenesis Services, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2019-2024)
 Table 26. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2025-2030)
 Table 28. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2019-2024)
 Table 30. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2025-2030)
 Table 32. North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2025-2030) & (US$ Million)
 Table 47. ACGT Company Details
 Table 48. ACGT Business Overview
 Table 49. ACGT Gene Site-Directed Mutagenesis Services Product
 Table 50. ACGT Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 51. ACGT Recent Development
 Table 52. Azenta Life Sciences Company Details
 Table 53. Azenta Life Sciences Business Overview
 Table 54. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product
 Table 55. Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 56. Azenta Life Sciences Recent Development
 Table 57. Biocompare Company Details
 Table 58. Biocompare Business Overview
 Table 59. Biocompare Gene Site-Directed Mutagenesis Services Product
 Table 60. Biocompare Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 61. Biocompare Recent Development
 Table 62. NovoPro Bioscience Inc. Company Details
 Table 63. NovoPro Bioscience Inc. Business Overview
 Table 64. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product
 Table 65. NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 66. NovoPro Bioscience Inc. Recent Development
 Table 67. Charles River Company Details
 Table 68. Charles River Business Overview
 Table 69. Charles River Gene Site-Directed Mutagenesis Services Product
 Table 70. Charles River Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 71. Charles River Recent Development
 Table 72. NZYtech Company Details
 Table 73. NZYtech Business Overview
 Table 74. NZYtech Gene Site-Directed Mutagenesis Services Product
 Table 75. NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 76. NZYtech Recent Development
 Table 77. Thermofisher Company Details
 Table 78. Thermofisher Business Overview
 Table 79. Thermofisher Gene Site-Directed Mutagenesis Services Product
 Table 80. Thermofisher Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 81. Thermofisher Recent Development
 Table 82. Creatve Biolabs Company Details
 Table 83. Creatve Biolabs Business Overview
 Table 84. Creatve Biolabs Gene Site-Directed Mutagenesis Services Product
 Table 85. Creatve Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 86. Creatve Biolabs Recent Development
 Table 87. Epoch Life Science Company Details
 Table 88. Epoch Life Science Business Overview
 Table 89. Epoch Life Science Gene Site-Directed Mutagenesis Services Product
 Table 90. Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 91. Epoch Life Science Recent Development
 Table 92. GeneToProtein Company Details
 Table 93. GeneToProtein Business Overview
 Table 94. GeneToProtein Gene Site-Directed Mutagenesis Services Product
 Table 95. GeneToProtein Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 96. GeneToProtein Recent Development
 Table 97. Genewiz Company Details
 Table 98. Genewiz Business Overview
 Table 99. Genewiz Gene Site-Directed Mutagenesis Services Product
 Table 100. Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 101. Genewiz Recent Development
 Table 102. GenScript Company Details
 Table 103. GenScript Business Overview
 Table 104. GenScript Gene Site-Directed Mutagenesis Services Product
 Table 105. GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2019-2024) & (US$ Million)
 Table 106. GenScript Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Gene Site-Directed Mutagenesis Services Picture
 Figure 2. Global Gene Site-Directed Mutagenesis Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Gene Site-Directed Mutagenesis Services Market Share by Type: 2023 VS 2030
 Figure 4. Synonymous Mutations Features
 Figure 5. Missense Mutation Features
 Figure 6. Nonsense Mutation Features
 Figure 7. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Gene Site-Directed Mutagenesis Services Market Share by Application: 2023 VS 2030
 Figure 9. Medical Industry Case Studies
 Figure 10. Biological Research Case Studies
 Figure 11. Others Case Studies
 Figure 12. Gene Site-Directed Mutagenesis Services Report Years Considered
 Figure 13. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 14. Global Gene Site-Directed Mutagenesis Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Gene Site-Directed Mutagenesis Services Market Share by Region: 2023 VS 2030
 Figure 16. Global Gene Site-Directed Mutagenesis Services Market Share by Players in 2023
 Figure 17. Global Top Gene Site-Directed Mutagenesis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Site-Directed Mutagenesis Services as of 2023)
 Figure 18. The Top 10 and 5 Players Market Share by Gene Site-Directed Mutagenesis Services Revenue in 2023
 Figure 19. North America Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. North America Gene Site-Directed Mutagenesis Services Market Share by Country (2019-2030)
 Figure 21. United States Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2019-2030)
 Figure 25. Germany Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. France Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. U.K. Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Italy Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Russia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Nordic Countries Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Region (2019-2030)
 Figure 33. China Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Japan Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. South Korea Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Southeast Asia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. India Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Australia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Gene Site-Directed Mutagenesis Services Market Share by Country (2019-2030)
 Figure 41. Mexico Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Brazil Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2019-2030)
 Figure 45. Turkey Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Saudi Arabia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. UAE Gene Site-Directed Mutagenesis Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. ACGT Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 49. Azenta Life Sciences Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 50. Biocompare Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 51. NovoPro Bioscience Inc. Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 52. Charles River Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 53. NZYtech Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 54. Thermofisher Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 55. Creatve Biolabs Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 56. Epoch Life Science Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 57. GeneToProtein Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 58. Genewiz Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 59. GenScript Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2019-2024)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String